Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancer

Paul Vinu Salachan,Martin Rasmussen,Benedicte Parm Ulhøi,Jørgen Bjerggaard Jensen,Michael Borre,Karina Dalsgaard Sørensen

DOI: https://doi.org/10.1002/ijc.34708

2023-09-02

International Journal of Cancer

Abstract:What's new? A better understanding of the spatial molecular heterogeneity within primary prostate tumors is necessary for developing better risk stratification and personalized treatment strategies. Using a novel spatial transcriptomics methodology, the authors studied immune‐stroma cross‐talk within the tumor microenvironment of primary prostate tumors from patients with metastatic disease. They revealed key contributions from cancer‐associated fibroblasts in determining disease aggressiveness, including potential interactions with protumorigenic macrophages. Moreover, they identified novel malignant cell populations and exploited spatial biology to identify a dysregulated immune signature associated with disease aggressiveness that holds biomarker potential at early and late disease stages. Prostate cancer (PCa) is a highly heterogeneous disease in terms of its molecular makeup and clinical prognosis. The prostate tumor microenvironment (TME) is hypothesized to play an important role in driving disease aggressiveness, but precise mechanisms remain elusive. In our study, we used spatial transcriptomics to explore for the first time the spatial gene expression heterogeneity within primary prostate tumors from patients with metastatic disease. In total, we analyzed 5459 tissue spots from three PCa patients comprising castration‐resistant (CRPC) and neuroendocrine (NEPC) disease stages. Within CRPC, we identified a T cell cluster whose activity might be impaired by nearby regulatory T cells, potentially mediating the aggressive disease phenotype. Moreover, we identified Hallmark signatures of epithelial‐mesenchymal transition in a cancer‐associated fibroblast (CAF) cluster, indicating the aggressive characteristic of the primary TME leading to metastatic dissemination. Within NEPC, we identified active immune‐stroma cross‐talk exemplified by significant ligand‐receptor interactions between CAFs and M2 macrophages. Further, we identified a malignant cell population that was associated with the down‐regulation of an immune‐related gene signature. Lower expression of this signature was associated with higher levels of genomic instability in advanced PCa patients (SU2C cohort, n = 99) and poor recurrence free survival in early‐stage PCa patients (TCGA cohort, n = 395), suggesting prognostic biomarker potential. Taken together, our study reveals the importance of whole transcriptome profiling at spatial resolution for biomarker discovery and for advancing our understanding of tumor biology.

oncology